Effect of a new local ointment for diabetic foot infectio

Phase 1

Completed

• Conditions: Diabetic foot infection; Metabolic and Endocrine - Diabetes; Skin - Dermatological conditions

• Registration Number: ACTRN12607000209493
• Lead Sponsor: Dr. Mostafa Yakoot; Dr. Mohamed Etman

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2007-04-16
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Patients presented with limb threatening diabetic foot infection. The lesions were then categorized into 3 main clinical groups we included the group 1 and 2 in analysis (1) skin ulcer (Wagner 1 and 2); (2) deep tissue infection and suspected osteomyelitis (Wagner 3).

Exclusion Criteria

We excluded group (3) with gangrenous lesion (Wagner 4 and 5).

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Percent of patients with complete healing, improvement of their lesions or treatment failure.[At 3 weeks, 9 and 24 weeks after intervention commencement.]

Secondary Outcome Measures

Name	Time	Method
Percent of patients suffering any adverse effects.[At week 1 and 9 after intervention commencement.];Percent of patients with large or ugly healing scars.[At week 9 after intervention commencement.]